AGR2 and cancer: The potential of these 4 molecules as a novel drug target also has been shown in a variety of studies: An accumulated knowledge on AGR2, PDE4D, NINJ2 and CDC25B have accelerated the drug discovery targeting these molecules in the other cancers.